Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2026-01-06 @ 10:10 PM
Study NCT ID:
NCT02697734
Status:
COMPLETED
Last Update Posted:
2021-11-01
First Post:
2016-02-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-03
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-27
First Submit QC Date:
None
Study First Post Date:
2016-03-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-07-26
Results First Submit QC Date:
None
Results First Post Date:
2021-10-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-09-09
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-10-20
Last Update Post Date:
2021-11-01
Last Update Post Date Type:
ACTUAL